Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could your morning cereal boost brainpower?

NCT ID NCT07782229

Knowledge-focused Sponsor: General Mills Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time

Summary

This study looks at whether a ready-to-eat breakfast cereal influences appetite and cognitive performance in healthy adults. Participants will eat the cereal and then complete computer-based attention tasks and rate their hunger and fullness. The goal is to see if this everyday breakfast food can support mental focus and appetite control.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ready-to-eat breakfast cereal
What this could lead to
If this cereal measurably improves appetite control or mental focus, it could point toward smarter breakfast choices for everyday cognitive and metabolic health.
What could go wrong
This is an early-stage, industry-sponsored study with subjective measures, so results may be modest or not apply to everyone. The cereal is a common food, so any effects are likely small.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 184 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy adults 18-70 years * Habitual breakfast cereal consumers (at least several times per month) * Body mass index 18.5-29.9 kg/m2 (based on self-reported weight and height) * Understand and willing to follow the study procedures, including having access to a tablet or laptop to use the online platforms for appetite and cognition measurement * Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial * Willing to abstain from strenuous exercise, consuming alcoholic drinks 24 hours before the test day * Willing to provide informed consent to participate in the study Exclusion Criteria: * Age or body mass index outside of the inclusion criteria * Pregnant or lactating women, or women who are planning to become pregnant during the study * Known food allergies, sensitivities, or intolerance to any food or food ingredients * Participating in another clinical trial for food, investigational drug, nutritional supplement, or lifestyle modification * Taking medications that affect appetite, metabolism or blood pressure * Presence of acute diseases or infection * Presence or history of chronic diseases * Diagnosed with an eating disorder * Restraint eaters as determined by a score \>4 from the Dutch Eating Behavior Questionnaire1 * Lost or gained 5 or more pounds in the past 3-months * On a weight loss diet or undergoing intermittent fasting * COVID-19 infection within the past 3 months * Subjects who do not eat cereal products * Subjects who do not understand or are not willing to follow the study procedures

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognition are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cognition

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Remote

    RECRUITING

    Minneapolis, Minnesota, 55430, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.